Cutaneous adverse events related to simultaneous nevirapine treatment and pneumococcal vaccination in HIV infected patients;Reacciones adversas cutáneas asociadas al tratamiento con nevirapina y vacunación antineumocócica en pacientes con infección por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 116, Issue 12, 2001, Pages 479-

  Estrada, V ^a   De Villar, N G P ^a   Serrano Rios M ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DEXCHLORPHENIRAMINE; LAMIVUDINE; LORATADINE; METHYLPREDNISOLONE; NEVIRAPINE; PNEUMO-23; PNEUMOCOCCUS VACCINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; DRUG INDUCED DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PAIN; PRURITUS; RASH; SKIN MANIFESTATION; VACCINATION;

EID: 0035977820     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71878-7     Document Type: Letter

References (4)

1. Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients
2. 23-Valent pneumococcai disease polysaccharide vaccine in HIV-infected Ugandan adults: Double-blind randomised and placebo controlled trial
3. Nevirapine-associated Stevens-Johnson syndrome
4. Vaccination-associated relapse of immune thrombocytopenia